Biogen Inc.
BIIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,632 | $1,162 | $2,962 | $1,728 |
| Dep. & Amort. | $673 | $495 | $518 | $488 |
| Deferred Tax | -$158 | -$306 | -$169 | -$427 |
| Stock-Based Comp. | $291 | $264 | $254 | $239 |
| Change in WC | -$155 | -$649 | -$890 | -$146 |
| Other Non-Cash | $592 | $581 | -$1,291 | $1,758 |
| Operating Cash Flow | $2,876 | $1,547 | $1,384 | $3,640 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$360 | -$311 | -$243 | -$295 |
| Net Acquisitions | -$1,075 | -$6,914 | $595 | $28 |
| Inv. Purchases | $0 | -$5,141 | -$3,449 | -$3,809 |
| Inv. Sales/Matur. | $552 | $8,289 | $4,661 | $3,499 |
| Other Inv. Act. | $84 | -$11 | $24 | $13 |
| Investing Cash Flow | -$799 | -$4,089 | $1,589 | -$564 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$650 | $187 | -$1,002 | -$170 |
| Stock Issued | -$31 | -$44 | -$2 | -$1 |
| Stock Repurch. | $0 | $0 | -$750 | -$1,800 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$6 | -$6 | -$115 |
| Financing Cash Flow | -$684 | $137 | -$1,760 | -$2,086 |
| Forex Effect | -$68 | $35 | -$56 | -$60 |
| Net Chg. in Cash | $1,325 | -$2,369 | $1,158 | $930 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,050 | $3,419 | $2,261 | $1,331 |
| End Cash | $2,375 | $1,050 | $3,419 | $2,261 |
| Free Cash Flow | $2,516 | $1,236 | $1,144 | $3,382 |